Cerevance Adds $47 Million in Series B-1 Extension to Advance Robust Clinical Pipeline



Comments are closed.

Digilens Raises $6.3M Investment To Expand Into Consumer Displays
Ultrahaptics Announces B Round Investment of £17.9M
Athira Pharma Raises $204m in Initial Public Offering
Sourav Kole, Managing Director, to speak at BIO International Convention